Which is the best management for women with normal cervical cytologic findings despite positivity for non-16/18 high risk human papillomaviruses?

M Wu, X Ma, H Li, B Li, C Wang, X Fan, A Fan… - Frontiers in Public …, 2022 - frontiersin.org
Women who test positive for the human papillomavirus (HPV) but have normal cytology
constitute the predominant subgroup of patients in the screening population in the post …

WarmStart colorimetric LAMP for the specific and rapid detection of HPV16 and HPV18 DNA

M Daskou, D Tsakogiannis, TG Dimitriou… - Journal of virological …, 2019 - Elsevier
Background and objectives Persistent infection with High-Risk HPV genotypes is the
principal cause for the development of cervical cancer with HPV16 and HPV18 to be the …

Рак шейки матки: профилактика и скрининг (новые данные)

КСР Дамиен, МА Союнов - Акушерство и гинекология: Новости …, 2018 - cyberleninka.ru
Несмотря на определенные успехи в профилактике рака шейки матки (РШМ), на
сегодняшний день ежегодно диагностируются 530 тыс. новых случаев заболевания, из …

Preliminary establishment and validation of a loop-mediated isothermal amplification assay for convenient screening of 13 types of high-risk human papillomaviruses …

L Zhang, Y Ju, H Hu, C Ma, Y Huang, L Gong… - Journal of Virological …, 2022 - Elsevier
Background The detection of human papillomaviruses (HPV) is a well-recognized strategy in
early screening and prevention of cervical cancer. However, it's hard to carry out in …

[HTML][HTML] Preliminary outcomes of the Cervical Cancer Screening Program of Northern Portugal: A snapshot

S Salta, JP Sequeira, J Lobo, A Sousa, H Sousa… - Journal of Infection and …, 2024 - Elsevier
Background Cervical cancer screening remains an essential preventive tool worldwide. First
line high-risk Human Papillomavirus (HrHPV) genotyping became gold standard for cervical …

Understanding the Dynamics of Human Papillomavirus and Diagnostic Discrepancies in Cervical Pathology: A Single Center Experience

M Zamurovic, A Tomic, A Pikula, S Simanic, A Knezevic… - Diagnostics, 2023 - mdpi.com
Cervical cancer (CC) is the most prevalent gynecological malignancy and a leading cause
of death among women. It is primarily caused by human papillomavirus (HPV) infection, with …

14-type HPV mRNA test in triage of HPV DNA-positive postmenopausal women with normal cytology

KC Asciutto, C Borgfeldt, O Forslund - BMC cancer, 2020 - Springer
Background During 2013 and 2016 the region of Skåne, Sweden started to analyse human
papillomavirus (HPV) and cytology in postmenopausal women 60–65 years of age. Our aim …

Role of HPV genotyping in risk assessment among cytology diagnosis categories: analysis of 4562 cases with cytology–HPV cotesting and follow-up biopsies

Y Ge, P Christensen, E Luna, D Armylagos… - International Journal of …, 2019 - ijgc.bmj.com
Objective Human papilloma virus (HPV) detection and genotyping are increasingly used in
clinical risk assessment. We aimed to analyze HPV genotyping performance in risk …

Comparison of the clinical performance of Aptima HPV assay and the Cobas 4800 platform in women with normal cytology and positive high-risk HPV

G Kir, D Dokmeci Guney, H Seneldir - Acta Cytologica, 2023 - karger.com
Introduction: According to the current American Society for Colposcopy and Cervical
Pathology (ASCCP) guidelines, patients with normal cytology results may be referred for …

Underrecognized Patterns of High-Grade Squamous Intraepithelial Lesion on ThinPrep Preparations: A Retrospective Analysis

A Goyal, JJ Heymann, SA Alperstein… - American Journal of …, 2021 - academic.oup.com
Objectives To identify less readily identifiable patterns of high-grade squamous
intraepithelial lesions (HSIL) in negative human papillomavirus (HPV)–positive …